This brand name is authorized in Estonia, Lithuania, Poland
The drug XANDERLA contains one active pharmaceutical ingredient (API):
|
1
Goserelin
UNII 6YUU2PV0U8 - GOSERELIN ACETATE
|
|
Goserelin is a synthetic analogue of naturally occurring LHRH. On chronic administration goserelin results in inhibition of pituitary LH secretion leading to a fall in serum testosterone concentrations in males and serum estradiol concentrations in females. |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| L02AE03 | Goserelin | L Antineoplastic and immunomodulating agents → L02 Endocrine therapy → L02A Hormones and related agents → L02AE Gonadotropin releasing hormone analogues |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1712911, 1712922, 1712944, 1712966, 1746749, 1746750 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1083388, 1083389, 1083390 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100366353, 100366360 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
